Women are the key decision makers in 80% of all healthcare choices, yet many brands fail to accurately portray them...
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Anatomage Inc., a pioneer in healthcare technology, announces the release of the world's...
Independent research firm honors ODAIA as a next-generation customer engagement platform for life sciences BOSTON, Nov. 18, 2024 /PRNewswire/ -- ODAIA today...
Mark Korth and Angela Hunt, RN, join as partners to help healthcare organizations advance clinical and operational performance MCLEAN, Va.,...
Collaboration to harness Lunit SCOPE Genotype Predictor for rapid and convenient prediction of non-small cell lung cancer driver mutations SEOUL,...
VANCOUVER, BC, Nov. 18, 2024 /PRNewswire/ - Ginkgo Health Inc., a pioneering technology startup aiming to reduce the global healthcare...
BEAVERTON, Ore., Nov. 18, 2024 /PRNewswire/ -- datma, a leading provider of federated Real-World Data platform and related analytical tools, today...
OPKO Healthcare's Veterinary Care Products to be Introduced at Asia's Largest Health and Nutrition Tradeshow Company Invited to Present at...
SANTA CLARA, Calif., Nov. 18, 2024 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a pioneer in developing and marketing technology...
Dr. Petri Vainio to become Executive ChairmanDr. Evis Hursever to become CEOScott Barry to become COOMarty Sutter to become Founding...
NEWTOWN, Pa., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company...
Next generation product may increase gastrointestinal luminal concentration while limiting system exposure LAVAL, QC / ACCESSWIRE / November 18, 2024...
EnteroBiotix Completes Phase 2 Study Recruitment of EBX-102-02 in Irritable Bowel Syndrome 122 patients with moderate to severe irritable bowel...
LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE/TSX:BHC),...
CHICAGO, IL / ACCESSWIRE / November 18, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,...
OPUVIZ™ is one of the first wave aflibercept biosimilars in EuropeOPUVIZ is the second European Commission (EC)-approved ophthalmology biosimilar under...
The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell therapies...
-- Four Pediatric patients treated in French early-access program achieved meaningful weight reduction at three months on setmelanotide therapy --...
NMD Pharma Initiates Phase 2 Study of NMD670 in Patients with Charcot-Marie-Tooth Disease Type 1 and 2 Aarhus, Denmark, 18...
Poster presentation highlighted results from confirmatory Phase 3 RESILIENT study of TNX-102 SL (sublingual cyclobenzaprine HCl) treatment demonstrating statistically significant...